Khantzian, E. J; Golden-Schulman, S. J; & McAuliffe, W. E. (2004). Group therapy. Textbook of substance abuse, Chapter 31.
Kouri, E. M; & Lukas, S. E. (2001). Electroencephalography, topographic mapping, and event-related potentials in substance abuse research.
Larsen, S. (2006). The healing power of neurofeedback. Healing art press.
Lawrence, J. T. (2002). Neurofeedback and your brain: A beginners manual. Faculty, NYU medical center & brain research lab, New York.
Lee, A. M; Meltzer, H. Y. (2001). Substance abuse in schizophrenia: Biological factors mediating co morbidity and the potential role of atypical antipsychotic drugs. Substance abuse in the mentally and physically disabled. Chapter 5.
Lehmann, L. P; Hubbard, J. R; & Martin, P. R. (2001). Substance abuse and depression. Substance abuse in the mentally and physically disabled. Chapter 3.
Lern Institut Basel GmbH. (2004). Introduction to Neurofeedback.
Loo, S. K; & Barkley R. A. (2005). Clinical utility of EEG in attention deficit hyperactivity disorder. Applied Neuropsychology. 12 (2), 64-76.
Marvin, W. S. (1995). Mathematically derived frequency correlated in cerebral function: Theoretical and clinical implications for neurofeedback training. Journal of Neurotherapy, 1 (2).
Masterpasqua, F; & Healey, K. N. (2003). Neurofeedback in psychological practice. Professional psychology: Research and practice, 34 (6), 652-656.
Millson, P. E; Challacombe, L; Villeneuve, P. J; Fischer, B; Strike, C. J; Myers, T; Shore, R; Hopkins, S; Raftis, S; & Pearson, M. (2004). Self perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease population. Department of public health science, university of Toroto.
Narimani, m &Rajabi, S. (2011). Evaluation of Alpha/Theta Neurofeedback Composed with Scott and Kaiser Protocol as a Treatment for
Substance Use Disorders. International Journal of Psychology.93,93-114
National Institute on Drug Abuse (1996). Craving in drug abuse and addiction. NIH Gruide, 25 (12). Available on: http://grant.nih.gov/grants/guide.
National institute on drug abuse. (2000). The brain: understanding neurobiology through the study of addiction. National institute of health, Seattle, Washington.
Newton, T. F; Cook, I. A; Kalechstein, A. D; Duran, S; Monoroy, F; Ling, W; & Leuchter, A. F. (2003). Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical neurophysiology, 114, 410-415.
Nuwer, M. (1997). Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology, 49, 277-292.
Ottomanelli, L. A; & Adinoff, B. (2001). Substance abuse and personality disorders: The impact of three personality clusters on prevalence, course, and treatment. Substance abuse in the mentally and physically disabled. Chapter 6.
Passant, U; RoseOn, I; Gustafson, L; & Englund,E. (2005). The heterogeneity of frontotemporal dementia with regard to initial symptoms, qEEG and neuropathology International journal of geriatric psychiatry, 20: 983-988.
Passini, F. T; Watson, C. G; Dehnel, L; Herder, J; & Watkins, B. (1977). Alpha wavw
biofeedback training therapy in alcoholics. Journal of clinical psychology, 33, 292-299.
Peniston, E. G; & Kulkosky, P. J. (1989). Alpha-theta brainwave training and beta-endorphin levels in alcoholics. Clinical and experimental research, 13, 271-279.
Peniston, E. G; & Saxby, E. (1995). Alpha-theta brainwave neurofeedback training: an effective treatment for male and female alcoholic with depressive symptoms. Journal of clinical psychology, 51.
Raymond, J; Varney, C; Parkinson, L. A; & Gruzelier, J. H. (2005). The effect of alpha/theta neurofeedback on personality and mood. Cognitive brain research, 23, 287-292.
Richard, A. J; Montoya, I. D; Nelson, R; & Spence, R. T. (1995). Effectiveness of adjust therapies in crack cocaine treatment. Journal of substance abuse treatment, 12, 401-413.
Rowan, A. J; Tolunsky, E. (2003). Primer of EEG. Butterworth Heinemann (an important of Elsevier), United state.
Schwartz, E. & Andrasik, F. (2003), Biofeedback: A practitioner’s guide. New York: Guilford Press.
Scott, W. C; Kaiser, D; Othmer, S; & Sideroff, S. I. (2005).Effects of an EEG biofeedback protocol on a mixed substance abusing population. The American Journal of Drug and Alcohol Abuse, 31:455-469.
Semple, S., Patterson, T., & Grant, I. (2005). Methamphetamine use and depressive symptoms among heterosexual men and women. Jornal of Substance Use, 10 (1), 31-47.
Silver, D; Edmonton; Alberta; Canada. (2006). Audio-visual attainment: Applying audio- visual entrainment technology for attention and learning.
Staci, A; Gruber, E. M; & Deborah, A. (2001). Neuropsychological correlates of drug abuse.
Sterman, M. B. (1996). Physiological origins and functional correlates of EEG rhythmic activities: Implications for self-regulation. Biofeedback and Self-Regulation, 21 (1), 3-49.
Sterman, M. B., Wywricka, W., & Roth, S. R. (1969). Electrophysiological correlates and neural substrates of alimentary behavior in the cat. Annals of the New York Academy of Science, 157, 723-739.
Sunift, L. P; & Mueller, T. (2001). Comorbidy of anxiety disorders in substance abuse. Substance abuse in the mentally and physically disabled. Chapter 2.
Unterrainer, H. F; Chen, M.J.-L & Gruzelier, J.H. (2013). EEG-neurofeedback and psychodynamic psychotherapy in a case of adolescent anhedonia with substance misuse: Mood/theta relations. International Journal of Psychophysiolog,1,12.
Walker, J., Lawson., R., Kozlowski., G. (2006). Current Status of QEEG and Neurofeedback in the Treatment of Clinical Depression. Neurotherapy Center Of Dallas and University of Texas Southwestern Medical School, Dallas
Weinstein, D. D; & Martin, P. R. (2001). Neurological disorders and head injuries. Substance abuse in the mentally and physically disabled. Chapter 13
.
Wilson, V. E; Peper, E; & Moss, D. (2006). Professional issue “The mind room” in Italian soccer training: the use of biofeedback and neurofeedback for optimum performance. Biofeedtjack, 34: 79-810.
Wyatt, S. A; & Schottenfeld, R. S. (2001). The relationship of substance abuse to the human immunodeficiency virus: Background and management. Substance abuse in the mentally and physically disabled. Chapter 10.
Wywricka, W; & Sterman, M. B. (1968). Instrumental conditioning of sensorimotor cortex EEG spindles in the waking cat. Physiology and Behavior, 3, 703-707.
Zaidel, E; & Barnea, A. (2005). Symposium IV: Quantitative EEG and neurofeedback. Brain and Cognition, 60, 329-330.
Zarate, C. A; & Tohen, M. F. (2001). Bipolar disorder and comorbid substance use disorders. Substance abuse in the mentally and physically disabled. Chapter 4.
پیوست‌ها
پیوست۱٫ پرسشنامه ولع مصرف هروئین( HCQ-45)
لطفا هر یک از جملات زیر را با دقت بخوانید . احساسی را که همین حالا نسبت به ماده مخدّر سوء مصرفی خود (هروئین، حشیش، تریاک، مورفین، یا….) دارید، در نظر بگیرید و میزان موافقت یا مخالفت خود با هرجمله را، با انتخاب یکی از ۷ گزینه مشخص کنید. لازم به ذکر است اطلاعات این پرسشنامه ، با رازداری کامل، فقط جهت استفاده عملی و درمانی بوده و هیچ گونه قضاوت ارزشی را برای شما به همراه ندارد.

۱٫اگر مواد مخدّر جلوی چشم من باشد، برایم دشوار خواهد بود خودم را کنترل کرده و ازآن مصرف نکنم.
کاملا موافقم  موافقم  نسبتا موافقم  بینابین  نسبتا مخالفم  مخالفم  کاملا مخالفم
۲٫مصرف مواد مخدّر برایم خوشایند نیست.